Annotation Detail

Information
Associated Genes
CDKN1B
Associated Variants
CDKN1B CYTOPLASMIC MISLOCALIZATION
CDKN1B CYTOPLASMIC MISLOCALIZATION
Associated Disease
breast cancer
Source Database
CIViC Evidence
Description
Cytoplasmic localization of p27 (CDKN1B) leads to lapatinib resistance in HER2+ breast cancer cell lines. p27 knockout resensitiuzed cells to lapatinib.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/860
Gene URL
https://civic.genome.wustl.edu/links/genes/914
Variant URL
https://civic.genome.wustl.edu/links/variants/360
Rating
3
Evidence Type
Predictive
Disease
Breast Cancer
Evidence Direction
Supports
Drug
Lapatinib
Evidence Level
D
Clinical Significance
Resistance
Pubmed
25587029
Drugs
Drug NameSensitivitySupported
LapatinibResitance or Non-Reponsetrue